Episode 507: ASCO 2026 - TALAPRO-3

<p>Neeraj Aggarwal joins the show to discuss the phase 3 TALAPRO-3 trial of talazoparib and enzlautamide in metastatic hormone-sensitive prostate cancer, focusing on trial design, efficacy, safety, and genetic subsets.</p><p><br></p><p><br></p>